Why Psoriatic Arthritis Goes Misdiagnosed for Years | GLP-1 Medications & Inflammation Breakthrough

Psoriatic arthritis (PsA) is the most commonly misdiagnosed form of inflammatory arthritis—and it's costing patients years of their lives. In this episode of Thriving with Arthritis, Dr. Diana Girnita and Dr. Vishnuteja Devalla explain why psoriatic arthritis symptoms are often mistaken for fibromyalgia, osteoarthritis, and other conditions, leading to diagnostic delays.

Discover the red flags doctors miss, the latest biologic treatments revolutionizing Psoriatic arthritis (PsA) care, and the groundbreaking connection between GLP-1 medications (like Tirzepatide, Zepbound, Mounjaro, Ozempic, and Wegovy) and reduced inflammation in autoimmune disease. 

Could these diabetes and weight-loss drugs be a game-changer for patients with inflammatory arthritis?

What You'll Learn:

• Why does psoriatic arthritis take an average of 5-7 years to diagnose correctly
• The subtle signs, symptoms, and the connection with other parts of the body like eyes, tendons, and the gut
• How insurance companied dictate care in choosing your treatment
• Cutting-edge biologic therapies
• The emerging science behind GLP-1 receptor agonists and systemic inflammation reduction
• Why traditional healthcare models fail chronic disease patients—and what we're doing differently

Keywords: psoriatic arthritis diagnosis, PsA symptoms, GLP-1 inflammation, GLP-1 autoimmune disease, rheumatoid arthritis vs psoriatic arthritis, biologic treatment psoriatic arthritis, inflammatory arthritis misdiagnosis, telehealth rheumatology, chronic inflammation treatment.